Global Antacids Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Antacids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global antacids market growth, size, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global antacids market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028.
Antacids, available without a prescription, are medications designed to counteract surplus stomach acid. Composed of calcium carbonate, aluminum hydroxide, magnesium hydroxide, or a blend of these substances, antacids function by interacting with stomach acid, diminishing its acidity, and easing discomfort. These remedies come in different formats, such as tablets, liquids, and chewable forms. Widely employed for prompt relief, they effectively address issues like heartburn, indigestion, and sour stomach.
Request a Sample Report:- https://www.imarcgroup.com/antacids-market/requestsample
Global Antacids Market Trends and Drivers:
The prevalence of conditions such as gastroesophageal reflux disease (GERD), acid reflux, heartburn, indigestion, peptic ulcers, and gastritis is on the rise. This uptick is notably driven by factors like the expanding elderly population, which is more susceptible to these ailments. Contributing to this trend are shifting lifestyles characterized by irregular dietary habits, disrupted sleep patterns, and sedentary behaviors. Additionally, the increasing awareness of digestive health and the ready availability of over-the-counter (OTC) medications are encouraging individuals to choose antacids, thereby fueling market growth. The growing trend of coffee consumption and participation in social drinking occasions, which may lead to digestive discomfort, is also positively impacting the market. Furthermore, the easy accessibility of antacids through both online and offline channels, including pharmacies and convenience stores, is further propelling market expansion.
Global Antacids Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited.
The report segmented the market on the basis of region, drug class, formulation type and distribution channel.
Breakup by Drug Class:
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Pro-Motility Agents
Breakup by Formulation Type:
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
Breakup by Region:
- North America
- United States
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800